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Man Must Measure
Except for Cardiologists!*
Sanjiv Kaul, MD
Portland, OregonWhen Lancelot Hogben (British mathematician,
zoologist, and humanist, 1895 to 1975) said “Man
Must Measure” (1) he had obviously not met a
cardiologist! Cardiologists interpret images from
various modalities: ultrasound, nuclear medicine,
cardiac magnetic resonance (CMR), computed to-
mography, and invasive angiography. Although there
are a vast number of published reports indicating
See page 1103
that quantification of images improves accuracy and
decreases observer error compared with visual in-
terpretation alone (2–4), cardiologists ignore this
evidence. Any measurements that are routinely
made and reported are performed either by techni-
cians (as in the case of ultrasound) or by automated
programs (as in the case of nuclear medicine). In
areas where technicians and automated methods are
not employed for quantification (such as the cardiac
catheterization laboratory), eye-balling is the norm,
even when clinically important decisions need to be
made—such as implanting a stent in a coronary
artery. Surprisingly, even clinical trials have suc-
cumbed to this penchant for refusing to measure:
one can now place an expensive implantable cardio-
verter defibrillator simply by visually estimating an
ejection fraction from an echocardiogram (5), where
in many instances the entire endocardium is not
even visible unless contrast is used.
Why is this so? In the old days, lack of digital
images and measurement programs was the main
excuse. Now the common excuse is lack of time in
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.From the Division of Cardiovascular Medicine, Oregon Health & Science
University, Portland, Oregon.a busy clinical practice. Some have even gone so far
as asserting that their “eye balling” is as accurate as
any measurement and so they do not need to stoop
so low as to actually make one (6)! I believe that the
main reason is that payers do not demand it. If
payers only reimbursed us for imaging tests if
reporting cardiologists had themselves made the
measurements, we would all soon be pretty facile
at using all the quantification programs that are
readily available to us. We would then be more
careful and hence more accurate. Something, we all
would agree, that our patients deserve.
One of the most elusive measurements in coro-
nary artery disease patients has been that of myo-
cardial blood flow (MBF). Single-photon emission
computed tomography can measure myocardial
tracer uptake that reflects relative myocardial blood
volume and not relative blood flow (7). Positron
emission tomography (PET) is limited to sites that
possess generators or cyclotrons. Myocardial con-
trast echocardiography has poor clinical penetra-
tion. Computed tomography requires very large
doses of radio-opaque dyes to measure myocardial
perfusion that can cause renal injury. Gadolinium–
diethylenetriamine pentaacetic acid can be safely
used as a CMR myocardial contrast agent in pa-
tients with adequate renal function and has become
popular for assessing myocardial viability. However,
it is not routinely used for MBF measurement,
despite its ability to do so (8).
What then is the relevance of the report by
Christian et al. (9) in this issue of iJACC? Although
the main purpose of the investigation was to com-
pare a 3.0-T with a 1.5-T magnet, they once again
showed the feasibility of CMR for quantification of
resting MBF and coronary flow reserve (CFR).
There are a vast number of published reports on the
clinical and physiological importance of CFR. Its
initial clinical application was for determining the
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1112hysiological significance of coronary stenosis (10).
ince then, it has been demonstrated that the most
mportant determinant of CFR is capillary resis-
ance (11), and any condition where capillary num-
er or dimension is reduced results in a decreased
FR (12). Similarly, if capillary resistance is ele-
ated by a high blood viscosity via an increase in
ematocrit or a decrease in erythrocyte negative
harge, deformability, or mobility, CFR will de-
rease (13). Thus, myocardial infarction (14), hy-
ertension (15), nonischemic dilated cardiomyopa-
hy (12), and hyperlipidemia (16) are all associated
ith reduced CFR, which has important prognostic
mplications.
Christian et al. (9) show that CMR can be used
o quantify MBF and CFR in an animal model. If
ne assumes that it can also be used to measure
BF and CFR noninvasively and reliably in hu-
ans, will this approach be used clinically, given the
ropensity of cardiologists to shy away from making
easurements? After all, the availability of CMR or
mage quality is not in question. Simply on the basis
f previous experience, the answer is “No.” For
nstance, it has been demonstrated that patient
utcome is better when coronary stent placement is
uided by fractional flow reserve rather than an-
iography (17). However, this measurement is not
outinely performed before coronary stent place-
ent. Neither is intravascular ultrasound routinely
sed to determine the success of stent deployment877– 83. field system: compaf reimbursement for stent placement was based on
erforming these tests then they would be per-
ormed. As a consequence, fewer stents would be
laced, and they would be better deployed, decreas-
ng cost and potentially improving outcome.
This is a sad commentary on our modus operandi.
e have such powerful imaging tools at our dis-
osal now that provide us with unbelievably de-
ailed anatomical and physiological information,
hich would not have seemed possible even a
ouple of decades ago. In the context of coronary
rtery disease, it should be a cause of excitement and
elebration that we can now quantify MBF and
FR noninvasively. But we don’t seem to care. We
efuse to make measurements that could further
efine our approach to patient care. This disparity
etween what we can do and what we actually do
idens year by year. It is not that introducing new
echnologies and discoveries to cardiologists is like
asting pearls before swine. We are not stupid, but
oo many of us seem to be comfortable with
ediocrity and the status quo. We seem also to not
e very interested in precision, especially if we have
o make the measurement ourselves! The conclu-
ion seems to be that we only do things that we have
o, not what we ought to.
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despite data to support its use for this purpose (18). Oregon 97239. E-mail: kauls@ohsu.edu.1
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